THYROGEN
Live / Registered — Registered and renewed (as of 29 Mar 2023)
What this means for you
Registered since 21 Jul 1992. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 21 Jul 2022).
Record
- Serial number
- 74089999
- Registration number
- 1702395
- Mark type
- Word mark
- Filed
- 15 Aug 1990
- Published for opposition
- 13 Aug 1991
- Registered
- 21 Jul 1992
- Next maintenance due
- 21 Jul 2022
- Attorney of record
- Karen Lim
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical compositions; namely, recombinant human thyrotropin for use in the diagnosis and treatment of thyroid conditions
Owner
- GENZYME CORPORATION, CAMBRIDGE, MA, US
- GENZYME THERAPEUTIC PRODUCTS LIMITED PAR, CAMBRIDGE, MA, US
- GENZYME CORPORATION, Cambridge, MA, US
- Genzyme Corporation, Framingham, MA, US
- Genzyme Corporation, Framingham, MA, US
- Genzyme Corporation, Framingham, MA, US
Prosecution history
- 29 Jan 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 29 Mar 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 29 Mar 2023 — REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
- 29 Mar 2023 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 29 Mar 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 19 Sept 2022 — TEAS SECTION 8 & 9 RECEIVED
- 21 Jul 2021 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 30 Jul 2012 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 30 Jul 2012 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 30 Jul 2012 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 30 Jul 2012 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 19 Jul 2012 — TEAS SECTION 8 & 9 RECEIVED
- 01 Feb 2008 — CASE FILE IN TICRS
- 18 Oct 2006 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 19 Sept 2005 — TEAS CHANGE OF OWNER ADDRESS RECEIVED